{
  "docId": "019de072-c9ff-713b-84f0-a86291a57ca3",
  "docSlug": "36aaeca628c43c1081cab946857c1896",
  "documentTitle": "Navidea Biopharmaceuticals | Investor Presentation Deck | 18 slides",
  "authorId": "navidea-biopharmaceuticals",
  "authorName": "Navidea Biopharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 18,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "revenue_buildup",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 39,
  "notes": "The chart uses a stacked bar format to distinguish between U.S. and EU sales contributions over time.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-c9ff-713b-84f0-a86291a57ca3/14",
  "deckHref": "/decks/019de072-c9ff-713b-84f0-a86291a57ca3",
  "deckJsonHref": "/decks/019de072-c9ff-713b-84f0-a86291a57ca3.json",
  "deckAnchorHref": "/decks/019de072-c9ff-713b-84f0-a86291a57ca3#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.48,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "chart",
      "text": "Upside Projected Net Revenue ($M)",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "beb8e4d8-d0c5-40db-a14d-7f904d827873",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.15,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "*Third-party valuation; rNPV: Risk-Adjusted Net Present Value.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "798d24bf-f79b-42a8-8603-cfaaf11f0b2c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.12,
        "x": 0.16,
        "y": 0.335
      },
      "kind": "legend",
      "text": "U.S. Sales; EU Sales",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1505e2f2-ed79-463e-9384-34f8c50b5fcd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.73
      },
      "kind": "table",
      "text": "2036 Peak Sales: $2.6 B; Aggregate Sales (2022-2036): $24.0 B; Probability Of Success: 52%; rNPV (2022-2036): $2.2 B",
      "attrs": null,
      "subkind": "kpi",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "766de90d-ff50-4905-b2ba-2fb6c8545da6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.75,
        "x": 0.04,
        "y": 0.13
      },
      "kind": "title",
      "text": "If Tc-Tilmanocept is incorporated into ACR/EULAR guidelines, 2036 U.S. / EU sales may approach ~$2.6 B",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1493b982-e4b0-4302-b869-e6ac3c82136b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.92,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Tc-Tilmanocept Upside Revenue Projections* (U.S. and EU)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dfab8c0a-c91c-4c8a-99e1-cdfc9919aff7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "b8020780-30ec-466e-92de-22af0b318211",
      "evidence": "chart/bar-stacked: Upside Projected Net Revenue ($M)",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 14,
      "from": 13,
      "beatId": "5d14c5a0-4206-4044-80a7-355df9ecb8a0",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Visualization",
      "beatSlug": "monroes-sequence-visualization",
      "evidence": "The revenue projections and upside revenue projections provide a visualization of the potential financial impact.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}